
浏览全部资源
扫码关注微信
重庆医科大学附属第二医院胃肠外科
纸质出版日期:2016,
扫 描 看 全 文
[1]王小虎,朱代华,段鹏飞,卓强.进展期近端胃癌D2根治术中切脾与保脾的疗效对比[J].重庆医科大学学报,2016,41(03):266-270.
Wang Xiaohu, Zhu Daihua, Duan Pengfei, et al. Comparation of surgical efficacy between splenectomy and splenic preservation in patients with advanced proximal gastric cancer[J]. Journal of Chongqing Medical University, 2016,41(3):266-270.
[1]王小虎,朱代华,段鹏飞,卓强.进展期近端胃癌D2根治术中切脾与保脾的疗效对比[J].重庆医科大学学报,2016,41(03):266-270. DOI: 10.13406/j.cnki.cyxb.000772.
Wang Xiaohu, Zhu Daihua, Duan Pengfei, et al. Comparation of surgical efficacy between splenectomy and splenic preservation in patients with advanced proximal gastric cancer[J]. Journal of Chongqing Medical University, 2016,41(3):266-270. DOI: 10.13406/j.cnki.cyxb.000772.
目的:对比研究联合脾切除术与保留脾脏的淋巴结清扫术在进展期近端癌根治术中的临床疗效。方法:选取我院自2008年1月至2010年5月期间收治的进展期近端胃癌患者91例
根据患者意愿选择手术方式
所有病例均行全胃根治术
其中术中保留脾脏(total gastreotomy
TG)者共48例
联合脾切除(total gastreotomy plus splenectomy
TGS)者43例
比较两组患者手术时间、术中出血量、住院时间、术后并发症发生率、淋巴结清扫效果及远期无瘤生存率。结果:TG组所需手术时间长于TGS组(P<0.05)
术后住院时间TGS组比TG组延长(P<0.05)。TGS组术后总体并发症发生率高于TG组(P<0.05)
其中感染性并发症发生率具有统计学差异(P<0.05)
2组患者再手术率和手术病死率无统计学差异(P>0.05)。2组患者在获取No.10和No.11淋巴结平均数量及No.10和No.11淋巴结转移率和转移度比较上
均无统计学差异(P>0.05)。2组术后1、3、5年无瘤生存率(DFS)均无统计学差异(P>0.05)
Log-rank法检测两组DFS Kaplan-Meier生存率曲线图
未见显著性差异(P>0.05)。结论:在进展期近端胃癌根治术中
保留脾脏的淋巴结清扫术与联合脾脏切除术相比
可达到同样的淋巴结清扫效果
同时又降低了手术并发症的发生
在远期生存率上
2组并无统计学差异
遂推荐保留脾脏的淋巴结清扫术。
Objective:To compare the surgical efficacy of splenectomy versus splenic preservation in the treatment of patients with advanced proximal gastric cancer. Methods:A total of 91 patients with advanced gastric proxima cancer from January 2008 to May2010 in our department were enrolled
including 48 cases in total gastreotomy(TG) group and 43 cases in total gastreotomy plus splenectomy(TGS)group. The general information
operation details
the results of postoperative complications and lymph node dissection between the two groups were analyzed and compared. The long-term efficacy was followed up. Results:The surgical procedures was longer in TG group
and the postoperative length of stay was longer in TGS group
with statistical significance differences(P<0.05). The rate of postoperative complications was higher(67.44% vs. 45.83%
P<0.05)in TGS group versus TG group
especially
in the comparison of septic complications(51.16% vs. 29.17%
P<0.05). The operative mortality and the reoperation rate were similar between the two groups(P >0.05). There was no significant difference in the mean number of harvested No.10 and No.11 lymph nodes
the metastatic lymph node ratio and the positive rate of the patients between the two groups(P >0.05). The 1-year
3-year
5-year disease free survival rates(DFS)in TG group were 76.9%
45.8%
36.7%
while those in TGS group were 81.0%
49.2%
41.4%
without statistically significant differences(P >0.05). There was no significant difference in Kaplan-Meier survival curves between two groups(P >0.05). Conclusion:With lower postoperative complications rate
spleen preserving lymphadenectomy has the same effect on lymph node dissection as splenectomy
for the patients with advanced gastric proximal cancer. There was no statistical difference in long-term survival between the two groups. The spleen preserving lymphadenectomy is worth promoting clinically.
进展期近端胃癌淋巴结清扫脾切除保留脾脏疗效
advanced gastric proximal cancerlymph node dissectionSplenectomyspleen preservationsurgical efficacy
0
浏览量
59
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621